Considerations for Clinical Trials of Staphylococcus aureus Bloodstream Infection in Adults
Sign Up to like & getrecommendations! Published in 2019 at "Clinical Infectious Diseases"
DOI: 10.1093/cid/ciy774
Abstract: Clinical trials for Staphylococcus aureus bloodstream infections (SAB) are broadly grouped into 2 categories: registrational trials intended to support regulatory approval of antibiotics for the treatment of SAB and strategy trials intended to inform clinicians… read more here.
Keywords: staphylococcus aureus; trials staphylococcus; aureus bloodstream; considerations clinical ... See more keywords
Comparison of Sequential Dalbavancin With Standard-of-Care Treatment for Staphylococcus aureus Bloodstream Infections
Sign Up to like & getrecommendations! Published in 2022 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofac335
Abstract: Abstract Background Dalbavancin (DAL) is a long-acting lipoglycopeptide with activity against Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA). This study investigates DAL as sequential therapy in S. aureus bloodstream infections (BSIs). Methods We conducted a… read more here.
Keywords: aureus bloodstream; day; bloodstream infections; standard care ... See more keywords
Statistical Process Control Charts for Monitoring Staphylococcus aureus Bloodstream Infections in Australian Health Care Facilities
Sign Up to like & getrecommendations! Published in 2019 at "Quality Management in Health Care"
DOI: 10.1097/qmh.0000000000000201
Abstract: Background: Staphylococcus aureus bloodstream infection (SAB) in health care settings contributes significantly to mortality, and improved processes are associated with reduced burden of infection. In Australia, health care–associated SAB (HA-SAB) rates are reported as a… read more here.
Keywords: health; control; staphylococcus aureus; health care ... See more keywords
Early-Stage Staphylococcus aureus Bloodstream Infection Causes Changes in the Concentrations of Lipoproteins and Acute-Phase Proteins and Is Associated with Low Antibody Titers against Bacterial Virulence Factors
Sign Up to like & getrecommendations! Published in 2020 at "mSystems"
DOI: 10.1128/msystems.00632-19
Abstract: S. aureus sepsis has a high complication and mortality rate. Given the limited therapeutic possibilities, effective prevention strategies, e.g., a vaccine, or the early identification of high-risk patients would be important but are not available.… read more here.
Keywords: acute phase; infection; aureus bloodstream; sabsi ... See more keywords
Comparison of Clinical Outcomes for Glycopeptides and Beta-Lactams in Methicillin-Susceptible Staphylococcus Aureus Bloodstream Infections
Sign Up to like & getrecommendations! Published in 2022 at "Yonsei Medical Journal"
DOI: 10.3349/ymj.2022.63.7.611
Abstract: Purpose This study aimed to provide compelling evidence of anti-staphylococcal beta-lactam use for methicillin-susceptible Staphylococcus aureus bloodstream infection (MSSA BSI). Materials and Methods We retrospectively collected data on patients with MSSA BSI who were admitted… read more here.
Keywords: aureus bloodstream; methicillin susceptible; staphylococcus aureus; definitive therapy ... See more keywords
[A retrospective analysis of clinical characteristics and prognostic factors for 152 cases of Staphylococcus aureus bloodstream infection].
Sign Up to like & getrecommendations! Published in 2023 at "Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]"
DOI: 10.3760/cma.j.cn112150-20220221-00161
Abstract: To understand the clinical characteristics of Staphylococcus aureus bloodstream infection and the main risk factors affecting clinical prognosis, providing a reference for clinical prevention and control of Staphylococcus aureus bloodstream infection. In this study, the… read more here.
Keywords: aureus bloodstream; prognosis; bloodstream infection; infection ... See more keywords